Lieff Cabraser partners Brendan Glackin and Dean Harvey will speak at the “Antitrust and Silicon Valley: New Themes and Direction in Competition Law and Policy” symposium at the Santa Clara University School of Law on Friday, March 1, 2019. The event, co-sponsored by the California Lawyers Association: Antitrust, UCL & Privacy Section, will feature a number of well-known antitrust and competition lawyers, experts, and scholars. [Read more…]
The Department of Justice and the state of North Carolina have reached a settlement agreement with Atrium Health, formerly known as Carolinas HealthCare System, in a federal lawsuit alleging the hospital giant violated antitrust laws and drove up patient healthcare costs
As reported by The Charlotte Observer, the 2016 lawsuit against Atrium Health, a billion dollar hospital chain and North Carolina’s largest health care provider, alleged that the company illegally reduced competition in the local healthcare market and set consumer prices so high that many patients were left struggling with bills they could not pay. While Atrium consistently raised costs for consumers, their top execs were receiving millions of dollars. [Read more…]
Lieff Cabraser partner Brendan P. Glackin will be participating in the Practising Law Institute’s (PLI) Basic Negotiation Skills 2018 Seminar on January 10 in San Francisco, California. Mr. Glackin will be featured on a distinguished slate of guests, presenting as part of a panel and live webcast titled “Strategizing Before a Negotiation” which will focus on how to prepare in advance of any negotiation, setting the goals and parameters of a negotiation, and how to consider the other side’s perspectives. [Read more…]
As reported by The Charlotte Observer, North Carolina Business Court Judge Michael Robinson has denied the Carolinas HealthCare System’s motion to dismiss a lawsuit accusing the hospital giant of driving up health care costs through illegal efforts to prevent competition. The lawsuit, filed by Lieff Cabraser and co-counsel in September of 2016, accuses CHS of placing improper contract restrictions on insurers forbidding them from guiding customers to lower-cost competing hospitals. [Read more…]
Lieff Cabraser partner Brendan Glackin has written an article for the Daily Journal entitled “Once a Witness is On the Stand, Things Can Only Go Wrong” about the challenges attorneys face when their clients take the stand in court. While the dramatic aspects of unexpected reveals are often larger in the criminal context, the piece notes that civil cases can nevertheless present worrisome challenges at the moment when clients are put before a courtroom to face open-ended questions. [Read more…]
Lieff Cabraser partner Brendan P. Glackin will be participating in the Practising Law Institute’s (PLI) California Trial Advocacy 2016 Seminar on August 3 in San Francisco, California. Mr. Glackin will be featured on a distinguished panel of guests, presenting as part of a panel and live webcast titled “Direct Examination; Trial Objections,” which will cover witness preparation, organizing direct examinations, the utilization of documents as evidence, and how to make key trial objections. [Read more…]
On an annual basis, federal judges of the U.S. Northern District of California hold a conference to discuss matters relating to the improvement of the administration of justice within the district. This year, Lieff Cabraser attorneys Kelly M. Dermody and Brendan P. Glackin will be participating in the Northern District of California 2016 Judicial Conference from April 8-10, 2016 in Napa Valley, California. [Read more…]
Lieff Cabraser attorneys selected as California Lawyers of the Year for antitrust case against Bayer over anticompetitive pricing of the blockbuster antibiotic drug Ciproflaxacin, sold as Cipro
California Lawyer has selected Lieff Cabraser partners Eric Fastiff, Brendan Glackin, and Dean Harvey as recipients of its 20th annual California Lawyer Attorneys of the Year (CLAY) Award. The prestigious award is given to lawyers whose work had a significant impact in the preceding year. The team was recognized for their outstanding work on In re Cipro Cases I & II, JCCP 4154/4220, a case that led the California Supreme Court to resoundingly endorse the rights of consumers to challenge pharmaceutical “pay-for-delay” settlements under California competition law.
Lieff Cabraser attorney Brendan P. Glackin will be speaking at Practising Law Institute’s (PLI) California Trial Advocacy 2015 Seminar on August 5, 2015 in San Francisco, California. Glackin will be featured on a distinguished panel of guests, presenting a session on "Preparing Your Case for Trial, Including Motions in Limine/Deposition Designations." This seminar will cover trial preparation, limine motions, jury selection, opening statements, witness preparation, direct and cross examination, experts, and closing arguments.
On April 2, 2014, from 12-2 p.m. EST, Lieff Cabraser attorney Brendan P. Glackin will speak at a live webcast on the Hatch-Waxman Act Updates in 2014, presented by The Knowledge Group, who describe the event as follows: "As pharmaceutical companies and related agencies continue to litigate in the dynamic Hatch-Waxman Act environment; recent developments in case law, further impact from the America Invents Act as well as agency enforcement activity will make for a complex year of developments. To better understand the issues and dynamics involving strategic alliances in the pharmaceutical industry, business leaders and their legal counsel must understand the legal and financial factors to help them better anticipate outcomes under this area of developing law."